Skip to content
The Policy VaultThe Policy Vault

Neupogen — Medica

Acute Lymphoblastic Leukemia (ALL) in a patient receiving chemotherapy

Initial criteria

  • Prescribed by or in consultation with an oncologist or hematologist

Approval duration

1 month